NDC 47781-925

pyrimethamine

Pyrimethamine

pyrimethamine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Pyrimethamine.

Product ID47781-925_4a17141e-1415-f527-6e45-07816b52bbb7
NDC47781-925
Product TypeHuman Prescription Drug
Proprietary Namepyrimethamine
Generic NamePyrimethamine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-09-17
Marketing CategoryANDA /
Application NumberANDA211271
Labeler NameAlvogen Inc.
Substance NamePYRIMETHAMINE
Active Ingredient Strength25 mg/1
Pharm ClassesDihydrofolate Reductase Inhibitor Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 47781-925-01

100 TABLET in 1 BOTTLE (47781-925-01)
Marketing Start Date2021-09-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "pyrimethamine" or generic name "Pyrimethamine"

NDCBrand NameGeneric Name
0480-3720PyrimethaminePyrimethamine
43598-672Pyrimethaminepyrimethamine
47781-925pyrimethaminepyrimethamine
48102-026PyrimethaminePYRIMETHAMINE
59651-590PyrimethaminePyrimethamine
72647-330Pyrimethaminepyrimethamine
69413-330Daraprimpyrimethamine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.